Grants and Contracts Details
Description
Leveraging innate immune networks to reverse resistance to check-point based immunotherapies in pancreatic and gastric cancer.
Status | Finished |
---|---|
Effective start/end date | 4/1/24 → 4/30/25 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.